Deppe Michael J 4

What Happened

• Michael J. Deppe, SVP, Corporate Controller & CAO of Quest Diagnostics (DGX), was granted restricted stock units (RSUs) totaling 2,054 shares on 2026-02-18 (366 RSUs + 1,688 RSUs reported as derivative). No cash was paid for the awards (grant price $0.00).
• To satisfy tax withholding on the vesting, 182 shares were delivered back to the issuer (83 shares at $210.01 = $17,431; 99 shares at $206.99 = $20,492), a total withholding value of $37,923. These withholding dispositions are routine and part of compensation settlement.

Key Details

• Transaction date: 2026-02-18; Form 4 filed 2026-02-20 (filed within typical 2-business-day window).
• Awards: 366 RSUs (A) and 1,688 RSUs (A, derivative) — total 2,054 RSUs granted.
• Withholding dispositions: 83 shares @ $210.01 (F) = $17,431; 99 shares @ $206.99 (F) = $20,492; total withheld = $37,923.
• Footnotes: F1 = award of restricted stock units; F2 = shares surrendered to issuer solely to cover tax withholding on RSU vesting.
• Shares owned after the transaction: not provided in the supplied data.

Context

• RSUs are compensation awards (no exercise price); the reported withholding is a cashless surrender to cover taxes and is routine — it does not necessarily imply a market view by the insider.
• The "derivative" notation simply indicates underlying shares of the RSU award that will convert to common stock upon vesting.